Insider Trading & Ownership - Nurix Therapeutics Inc. (NRIX)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Nurix Therapeutics Inc.
Goto Prev, 0, 1, 2, 3, 4, 5, Next
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2021-03-16
Sale		 2021-03-16
6:50 pm		 Nurix Therapeutics Inc. NRIX Hansen Gwenn
Chief Scientific Officer		 800 $45 $36,000 88,070
(Direct)		 View
2021-03-10
Sale		 2021-03-11
5:35 pm		 Nurix Therapeutics Inc. NRIX Ring Christine
General Counsel		 2,000 $41.27 $82,539 118,471
(Direct)		 View
2021-03-08
Sale		 2021-03-09
4:04 pm		 Nurix Therapeutics Inc. NRIX Beaurang Pierre
Chief Business Officer		 7,500 $37.02 $277,678 123,392
(Indirect
Direct)		 View
2021-03-01
Sale		 2021-03-02
5:29 pm		 Nurix Therapeutics Inc. NRIX Hansen Gwenn
Chief Scientific Officer		 800 $35.95 $28,760 88,870
(Direct)		 View
2021-02-24
Sale		 2021-02-25
4:18 pm		 Nurix Therapeutics Inc. NRIX van Houte Hans
Chief Financial Officer		 35,419 $39.9 $1,413,218 65,667
(Direct)		 View
2021-02-22
Sale		 2021-02-23
6:04 pm		 Nurix Therapeutics Inc. NRIX van Houte Hans
Chief Financial Officer		 5,330 $39.93 $212,839 97,753
(Direct)		 View
2021-02-18
Sale		 2021-02-22
4:09 pm		 Nurix Therapeutics Inc. NRIX van Houte Hans
Chief Financial Officer		 13,583 $35.46 $481,621 69,750
(Direct)		 View
2021-02-18
Sale		 2021-02-22
4:08 pm		 Nurix Therapeutics Inc. NRIX Ring Christine
General Counsel		 2,000 $35.88 $71,750 119,666
(Direct)		 View
2021-02-18
Sale		 2021-02-22
4:07 pm		 Nurix Therapeutics Inc. NRIX Hansen Gwenn
Chief Scientific Officer		 800 $36.27 $29,018 87,866
(Direct)		 View
2021-02-18
Sale		 2021-02-22
4:06 pm		 Nurix Therapeutics Inc. NRIX Beaurang Pierre
Chief Business Officer		 15,000 $35.49 $532,352 101,773
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2021-03-25
Exercise		 2021-03-25
7:23 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Beaurang Pierre
Chief Business Officer		 4,330 $0.84 123,392
(Direct)		 View
2021-03-25
Exercise		 2021-03-25
7:23 pm		 N/A
2026-01-27		 Nurix Therapeutics Inc. NRIX Beaurang Pierre
Chief Business Officer		 4,330 $0 123,392
(Direct)		 View
2021-03-16
Exercise		 2021-03-16
6:50 pm		 N/A
2030-02-26		 Nurix Therapeutics Inc. NRIX Hansen Gwenn
Chief Scientific Officer		 800 $0 88,070
(Direct)		 View
2021-03-16
Exercise		 2021-03-16
6:50 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Hansen Gwenn
Chief Scientific Officer		 800 $7.26 88,070
(Direct)		 View
2021-03-10
Exercise		 2021-03-11
5:35 pm		 N/A
2029-09-30		 Nurix Therapeutics Inc. NRIX Ring Christine
General Counsel		 2,000 $0 118,471
(Direct)		 View
2021-03-10
Exercise		 2021-03-11
5:35 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Ring Christine
General Counsel		 2,000 $1.86 118,471
(Direct)		 View
2021-03-08
Exercise		 2021-03-09
4:04 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Beaurang Pierre
Chief Business Officer		 7,500 $0.84 123,392
(Direct)		 View
2021-03-08
Exercise		 2021-03-09
4:04 pm		 N/A
2026-01-27		 Nurix Therapeutics Inc. NRIX Beaurang Pierre
Chief Business Officer		 7,500 $0 123,392
(Direct)		 View
2021-03-01
Exercise		 2021-03-02
5:29 pm		 N/A
2030-02-26		 Nurix Therapeutics Inc. NRIX Hansen Gwenn
Chief Scientific Officer		 800 $0 88,870
(Direct)		 View
2021-03-01
Exercise		 2021-03-02
5:29 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Hansen Gwenn
Chief Scientific Officer		 800 $7.26 88,870
(Direct)		 View
2021-02-24
Exercise		 2021-02-25
4:18 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX van Houte Hans
Chief Financial Officer		 20,393 $1.2 65,667
(Direct)		 View
2021-02-24
Exercise		 2021-02-25
4:18 pm		 N/A
2028-03-01		 Nurix Therapeutics Inc. NRIX van Houte Hans
Chief Financial Officer		 35,419 $0 65,667
(Direct)		 View
2021-02-24
Exercise		 2021-02-25
4:18 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX van Houte Hans
Chief Financial Officer		 1,829 $7.26 65,667
(Direct)		 View
2021-02-24
Exercise		 2021-02-25
4:18 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX van Houte Hans
Chief Financial Officer		 13,197 $1.86 65,667
(Direct)		 View
2021-02-22
Exercise		 2021-02-23
6:04 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX van Houte Hans
Chief Financial Officer		 3,913 $1.2 97,753
(Direct)		 View
2021-02-22
Exercise		 2021-02-23
6:04 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX van Houte Hans
Chief Financial Officer		 1,417 $0.84 97,753
(Direct)		 View
2021-02-22
Exercise		 2021-02-23
6:04 pm		 N/A
2026-04-26		 Nurix Therapeutics Inc. NRIX van Houte Hans
Chief Financial Officer		 5,330 $0 97,753
(Direct)		 View
2021-02-18
Exercise		 2021-02-22
4:09 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX van Houte Hans
Chief Financial Officer		 13,583 $0.84 69,750
(Direct)		 View
2021-02-18
Exercise		 2021-02-22
4:09 pm		 N/A
2026-01-27		 Nurix Therapeutics Inc. NRIX van Houte Hans
Chief Financial Officer		 13,583 $0 69,750
(Direct)		 View
2021-02-18
Exercise		 2021-02-22
4:08 pm		 N/A
2029-09-30		 Nurix Therapeutics Inc. NRIX Ring Christine
General Counsel		 2,000 $0 119,666
(Direct)		 View
2021-02-18
Exercise		 2021-02-22
4:08 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Ring Christine
General Counsel		 2,000 $1.86 119,666
(Direct)		 View
2021-02-18
Exercise		 2021-02-22
4:07 pm		 N/A
2030-02-26		 Nurix Therapeutics Inc. NRIX Hansen Gwenn
Chief Scientific Officer		 800 $0 87,866
(Direct)		 View
2021-02-18
Exercise		 2021-02-22
4:07 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Hansen Gwenn
Chief Scientific Officer		 800 $7.26 87,866
(Direct)		 View
2021-02-18
Exercise		 2021-02-22
4:06 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Beaurang Pierre
Chief Business Officer		 9,107 $0.84 101,773
(Direct)		 View
2021-02-18
Exercise		 2021-02-22
4:06 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Beaurang Pierre
Chief Business Officer		 2,096 $9.57 101,773
(Direct)		 View
2021-02-18
Exercise		 2021-02-22
4:06 pm		 N/A
2026-01-27		 Nurix Therapeutics Inc. NRIX Beaurang Pierre
Chief Business Officer		 15,000 $0 101,773
(Direct)		 View
2021-02-18
Exercise		 2021-02-22
4:06 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Beaurang Pierre
Chief Business Officer		 3,797 $7.26 101,773
(Direct)		 View
2021-02-11
Option Award		 2021-02-12
7:27 pm		 N/A
2031-02-10		 Nurix Therapeutics Inc. NRIX van Houte Hans
Chief Financial Officer		 40,000 $0 40,000
(Direct)		 View
2021-02-11
Option Award		 2021-02-12
7:24 pm		 N/A
2031-02-10		 Nurix Therapeutics Inc. NRIX SANDS ARTHUR T
President, CEO		 150,000 $0 150,000
(Direct)		 View
2021-02-11
Option Award		 2021-02-12
7:23 pm		 N/A
2031-02-10		 Nurix Therapeutics Inc. NRIX Ring Christine
General Counsel		 40,000 $0 40,000
(Direct)		 View
2021-02-11
Option Award		 2021-02-12
7:21 pm		 N/A
2031-02-10		 Nurix Therapeutics Inc. NRIX Hansen Gwenn
Chief Scientific Officer		 60,000 $0 60,000
(Direct)		 View
2021-02-11
Option Award		 2021-02-12
7:21 pm		 N/A
2031-02-10		 Nurix Therapeutics Inc. NRIX Beaurang Pierre
Chief Business Officer		 40,000 $0 40,000
(Direct)		 View
2021-02-04
Other		 2021-02-08
4:11 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Third Rock Ventures III L.P.
Third Rock Ventures GP III L.P.
TRV GP III LLC
STARR KEVIN P
TEPPER ROBERT I
LEVIN MARK J
10% Owner		 914,216 $0 5,559,240
(Direct)		 View
2020-11-30
Exercise		 2020-12-01
9:32 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Hansen Gwenn
Chief Scientific Officer		 12,000 $0.84 43,333
(Direct)		 View
2020-11-30
Exercise		 2020-12-01
9:32 pm		 N/A
2026-02-10		 Nurix Therapeutics Inc. NRIX Hansen Gwenn
Chief Scientific Officer		 12,000 $0 43,333
(Direct)		 View
2020-10-21
Option Award		 2020-10-23
5:22 pm		 N/A
2030-10-20		 Nurix Therapeutics Inc. NRIX SANDS ARTHUR T
President, CEO		 804,170 $0 804,170
(Direct)		 View
2020-07-28
Conversion		 2020-07-30
8:08 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner		 784,313 $0 784,313
(Direct)		 View
2020-07-28
Conversion		 2020-07-30
7:37 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Redmile Group LLC
Green Jeremy
10% Owner		 1,176,470 $0 1,176,470
(Indirect)		 View
2020-07-28
Conversion		 2020-07-29
9:53 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX COLUMN GROUP L P
Svennilson Peter
10% Owner		 6,672,548 $0 686,274
(Direct)		 View
2020-07-28
Conversion		 2020-07-29
9:49 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX COLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP II LP
Column Group II GP LP
PONOI CAPITAL LP
Ponoi Management LLC
Ponoi II Management LLC
Ponoi Capital II LP
Kutzkey Tim
GOEDDEL DAVID V
10% Owner		 6,672,548 $0 686,274
(Direct)		 View
2020-07-28
Conversion		 2020-07-29
9:19 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Third Rock Ventures III L.P.
Third Rock Ventures GP III L.P.
TRV GP III LLC
LEVIN MARK J
STARR KEVIN P
TEPPER ROBERT I
10% Owner		 5,422,549 $0 5,422,549
(Direct)		 View
2020-07-28
Conversion		 2020-07-29
5:33 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Tjian Robert
Director		 91,666 $0 124,999
(Indirect)		 View

Ownership		 2020-07-23
9:25 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner		 0 $0 784,313
(Direct)		 View

Ownership		 2020-07-23
8:10 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Redmile Group LLC
Green Jeremy
10% Owner		 0 $0 1,176,470
(Indirect)		 View

Ownership		 2020-07-23
7:29 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX COLUMN GROUP L P
Svennilson Peter
10% Owner		 0 $0 6,774,214
(Direct)		 View

Ownership		 2020-07-23
7:26 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX COLUMN GROUP L P
COLUMN GROUP GP LP
COLUMN GROUP II LP
Column Group II GP LP
PONOI CAPITAL LP
Ponoi Management LLC
Ponoi II Management LLC
Ponoi Capital II LP
Kutzkey Tim
GOEDDEL DAVID V
10% Owner		 0 $0 6,774,214
(Direct)		 View

Ownership		 2020-07-23
6:54 pm		 N/A
2029-12-22		 Nurix Therapeutics Inc. NRIX GREGORY JULIA P
Director		 0 $0 51,666
(Direct)		 View

Ownership		 2020-07-23
6:53 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Kunkel Lori Anne
Director		 0 $0 58,332
(Direct)		 View

Ownership		 2020-07-23
6:52 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Lacey David L.
Director		 0 $0 99,999
(Direct)		 View

Ownership		 2020-07-23
6:52 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Tjian Robert
Director		 0 $0 143,332
(Indirect)		 View

Ownership		 2020-07-23
6:51 pm		 N/A
2030-05-27		 Nurix Therapeutics Inc. NRIX Chen Leon
Director		 0 $0 18,333
(Direct)		 View

Ownership		 2020-07-23
6:50 pm		 N/A
2030-05-27		 Nurix Therapeutics Inc. NRIX Tong Jeffrey K
Director
10% Owner		 0 $0 18,333
(Direct)		 View

Ownership		 2020-07-23
6:49 pm		 N/A
2029-09-30		 Nurix Therapeutics Inc. NRIX Ring Christine
General Counsel		 0 $0 256,665
(Direct)		 View

Ownership		 2020-07-23
6:48 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX Beaurang Pierre
Chief Business Officer		 0 $0 391,771
(Indirect)		 View

Ownership		 2020-07-23
6:47 pm		 N/A
2026-02-10		 Nurix Therapeutics Inc. NRIX Hansen Gwenn
Chief Scientific Officer		 0 $0 298,331
(Direct)		 View

Ownership		 2020-07-23
6:46 pm		 N/A
2028-03-01		 Nurix Therapeutics Inc. NRIX van Houte Hans
Chief Financial Officer		 0 $0 271,665
(Direct)		 View

Ownership		 2020-07-23
6:45 pm		 N/A
N/A		 Nurix Therapeutics Inc. NRIX SANDS ARTHUR T
President, CEO		 0 $0 1,429,204
(Direct)		 View
Goto Prev, 0, 1, 2, 3, 4, 5, Next